Church & Dwight (CHD)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-29
$106.00+1.19%
Close 2026-10-29 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-29
Research Workspace
Put CHD beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Household Products is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 3% over the past year.
View GrowthManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look high — the market is pricing in about 31% growth a year, above the roughly 4% analysts expect, leaving little room for error.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskCHD’s case rests on strong recent performance within a supportive sector, despite modest revenue growth. Revenue growth accelerated from 0.2% to 1.6%, while Q2 FY2026 earnings were inline. CHD trades at 30× P/E versus a 16× peer median and 28× its history. The market is pricing in more growth than our forecast. A 19% next-quarter miss probability adds risk, and the peer premium must be earned. Peer multiples imply a price about 31% below where it trades; our read remains intact. This read is provisional.
Trailing returns as of 2026-10-29. CHD is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering CHD (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for CHD in the last 4 months.
Continue this research
Compare CHD with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CHD Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Household Products — fair value, gap to price, and forward P/E.
Compare the value case
Put CHD next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Q3 results and an outlook raised above consensus confirm improving execution and strengthen the FY26 outlook.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $106.00
The last 12 months of price, then the range of analyst 12-month targets from today’s $106.00.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Profit and revenue growth with a firmer outlook support the company’s FY26 objectives.
Advances: Increase EPS by 18% to 22% in 2026
Affirms growth model aligns with EPS increase objective.
Supports growth thesis with volume-driven growth insights.
Advances: Drive organic sales growth of approximately 4% to 5% in 2026
Projected organic growth and cash generation support core 2026 objectives.
Advances: Focus on innovation to drive approximately half of organic growth
Portfolio changes and higher advertising reportedly supported Q2 sales growth.
Advances: Drive organic sales growth of approximately 4% to 5% in 2026
Q2 sales outperformance supports the organic-growth objective.
Advances: Increase EPS by 18% to 22% in 2026
Raised outlook after organic-sales growth strengthens confidence in 2026 targets.